The American Association of Clinical Endocrinologists/American College of Endocrinology consensus statement also recommends either a GLP-1RA or SGLT2i as a preferred treatment option (either as first-line or, more typically, second-line treatment after metformin) over alternative options such as a dipeptidyl peptidase-4 inhibitor, a thiazolidinedione (TZD), or a sulfonylurea (SU), for patients with T2D and ASCVD, stage 3 CKD, or heart failure with reduced ejection fraction [2]
Some see rapid results
86% of adults taking Wegovy lost 5% or more weight, compared to 31% taking placebo 69% of adults taking Wegovy lost 10% or more weight, compared to 12% taking placebo 51% of adults taking Wegovy lost 15% or more weight, compared to 5% taking placebo* About 1 in 3 adults lost 46 lb or more (20% weight loss) while only 1.7% of adults on placebo experienced the same weight loss
This weight loss is often attributed to the medications effects on appetite suppression, reduced calorie intake, and improved metabolic function
(786) 294-6054 or submit the form well reach out when its best for you
CLA is conjugated linoleic acid which helps the body to manage and regulate how fat energy is used